Nintedanib esylate
NDC 33342-551, Nintedanib esylate, capsule, from Macleods Pharmaceuticals Limited.
- Product NDC
- 33342-551
- Status
- Listed
- Labeler
- Macleods Pharmaceuticals Limited
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA219926
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/33342-551 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NINTEDANIB ESYLATE150 mg/1
Pharmacologic classes
Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 33342-551-09 | 33342055109 | 60 CAPSULE in 1 BOTTLE (33342-551-09) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/9925b305-c1fb-43b6-a5fd-e03f14f28e6c
Use it
Look up 33342-551 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/33342-551 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 33342-551. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.